We are live on ! Find out more
FMS icon

Fresenius Medical Care

175 hedge funds and large institutions have $352M invested in Fresenius Medical Care in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 61 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 2.91%2.91% (+0%)

3% less capital invested

Capital invested by funds: $362M → $352M (-$10.8M)

4% less funds holding

Funds holding: 182175 (-7)

19% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 31

34% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 61

Holders
175
Holders Change
-7
Holders Change %
-3.85%
% of All Funds
3.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
40
Reduced
61
Closed
31
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HJGA
26
Hardman Johnston Global Advisors
Connecticut
$2.11M -$63.4K -1,600 -3%
Renaissance Technologies
27
Renaissance Technologies
New York
$2.07M +$974K +24,600 +88%
CGH
28
Crossmark Global Holdings
Texas
$2.02M -$143K -3,619 -7%
Arrowstreet Capital
29
Arrowstreet Capital
Massachusetts
$1.8M -$3.21M -80,911 -64%
SB
30
Suntrust Banks
Georgia
$1.73M -$21.9K -554 -1%
US Bancorp
31
US Bancorp
Minnesota
$1.72M -$778K -19,637 -31%
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$1.46M +$631K +15,917 +75%
DPIM
33
Duff & Phelps Investment Management
Illinois
$1.38M -$2.2M -55,571 -61%
Comerica Bank
34
Comerica Bank
Texas
$1.27M -$18.2K -459 -1%
SG Americas Securities
35
SG Americas Securities
New York
$1.17M -$47.2K -1,191 -4%
SAM
36
Silvercrest Asset Management
New York
$1.09M +$1.1M +27,870 New
Natixis Advisors
37
Natixis Advisors
Massachusetts
$1M -$374K -9,442 -27%
MHC
38
Meyer Handelman Company
New York
$943K
ECM
39
ExodusPoint Capital Management
New York
$927K +$935K +23,600 New
UBS Group
40
UBS Group
Switzerland
$920K -$38.1K -963 -4%
SC
41
Searle & Co
Connecticut
$915K
CIM
42
Confluence Investment Management
Missouri
$838K +$22K +556 +3%
Stifel Financial
43
Stifel Financial
Missouri
$813K +$19.3K +486 +2%
Squarepoint
44
Squarepoint
New York
$750K +$757K +19,101 New
CSS
45
Cubist Systematic Strategies
Connecticut
$730K +$401K +10,111 +119%
GCAC
46
Guardian Capital Advisors (Canada)
Ontario, Canada
$668K +$72.3K +1,825 +12%
JMH
47
J.M. Hartwell
New York
$648K
KB
48
Kimelman & Baird
New York
$639K
Pacer Advisors
49
Pacer Advisors
Pennsylvania
$610K -$41.4K -1,044 -6%
HighTower Advisors
50
HighTower Advisors
Illinois
$601K +$9.43K +238 +2%

FMS Hedge Fund Activity: Q2 2019 in Review

175 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q2 2019, worth a combined $352M — down 3% from $362M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of FMS and 25 opened new positions — a net loss of 6 holders — while 61 trimmed existing stakes and 40 added.

The largest buyer was Morgan Stanley, adding an estimated $25.5M. The largest seller was Renaissance Group, exiting entirely with an estimated $15.3M sold.

  • 175 institutional investors held Fresenius Medical Care (FMS) as of Q2 2019, down from 182 in Q1 2019.
  • Funds reported $352M of Fresenius Medical Care stock for Q2 2019, down 3% quarter-over-quarter.
  • 25 funds opened new Fresenius Medical Care positions in Q2 2019 and 31 closed out, a net change of -6 holders.
  • The largest Fresenius Medical Care buyer in Q2 2019 was Morgan Stanley, an estimated $25.5M added.
  • The largest Fresenius Medical Care seller in Q2 2019 was Renaissance Group, an estimated $15.3M sold.

Based on aggregated 13F filings for Q2 2019.